CoChat

Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons

Open access
Robbins, Jacqueline P., Perfect, Leo, Ribe, Elena M., Maresca, Marcello, Dangla-Valls, Adrià, Foster, Evangeline M., Killick, Richard, Nowosiad, Paulina, Reid, Matthew J., Polit, Lucia Dutan, Nevado, Alejo J., Ebner, Daniel, Bohlooly-Y, Mohammad, Buckley, Noel, Pangalos, Menelas N., Price, Jack, Lovestone, Simon · 2018 · Frontiers in Neuroscience
Cited by 54

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Our understanding of the molecular processes underlying Alzheimer’s disease (AD) is still limited, hindering the development of effective treatments and highlighting the need for human-specific models. Advances in identifying components of the amyloid cascade are progressing, including the role of the protein clusterin in mediating β-amyloid (Aβ) toxicity. Mutations in the clusterin gene (CLU), a major genetic AD risk factor, are known to have important roles in Aβ processing. Here we investigate how CLU mediates Aβ-driven neurodegeneration in human induced pluripotent stem cell (iPSC)-derived neurons. We generated a novel CLU-knockout iPSC line by CRISPR/Cas9-mediated gene editing to investigate Aβ-mediated neurodegeneration in cortical neurons differentiated from wild type and CLU knockout iPSCs. We measured response to Aβ using an imaging assay and measured changes in gene expression using qPCR and RNA sequencing. In wild type neurons imaging indicated that neuronal processes degenerate following treatment with Aβ25-35 peptides and Aβ1-42 oligomers, in a dose dependent manner, and that intracellular levels of clusterin are increased following Aβ treatment. However, in CLU knockout neurons Aβ exposure did not affect neurite length, suggesting that clusterin is an important component of the amyloid cascade. Transcriptomic data were analysed to elucidate the pathways responsible for the altered response to Aβ in neurons with the CLU deletion. Four of the five genes previously identified as downstream to Aβ and Dkk1 proteins in an Aβ-driven neurotoxic pathway in rodent cells were also dysregulated in human neurons with the CLU deletion. Alzheimer’s disease and lysosome pathways were the most significantly dysregulated pathways in the CLU knockout neurons, and pathways relating to cytoskeletal processes were most dysregulated in Aβ treated neurons. The absence of neurodegeneration in the CLU knockout neurons in response to Aβ compared to the wild type neurons supports the role of clusterin in Aβ-mediated AD pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2018.00504

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 54

Metadata

Authors
Robbins, J. P., Perfect, L., Ribe, E. M., Maresca, M., Dangla-Valls, A., Foster, E. M., Killick, R., Nowosiad, P., Reid, M. J., Polit, L. D., Nevado, A. J., Ebner, D., Bohlooly-Y, M., Buckley, N., Pangalos, M. N., Price, J., & Lovestone, S.
Venue
Frontiers in Neuroscience
Published
2018-07-25
Volume
12
Pages
504-504
ISSN
1662-453X (ISSN-L)
OpenAlex
W2883129597
Cited by
54
References
28
FWCI
3.41
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons. https://app.cochat.ai/papers/10.3389/fnins.2018.00504
The paper
Robbins, J. P., Perfect, L., Ribe, E. M., Maresca, M., Dangla-Valls, A., Foster, E. M., Killick, R., Nowosiad, P., Reid, M. J., Polit, L. D., Nevado, A. J., Ebner, D., Bohlooly-Y, M., Buckley, N., Pangalos, M. N., Price, J., & Lovestone, S. (2018). Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00504

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.